SCHEMBL8096897

SCHEMBL8096897

CCC(=O)O[C@H](C(=O)O)C(N)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 18/20 0.54
SLC1A1 P43005 18/20 0.54
SLC1A3 P43003 17/20 0.54
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
MMP13 P45452 1/20 0.42
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC7A5 Q01650 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8096891 1.00 SLC1A2 (0.54) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL8096888 1.00 SLC1A2 (0.54) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL4953255 0.84 MMP1 (0.50) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL19846200 0.84 MMP1 (0.50) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL13583919 0.79 SLC7A5 (0.44) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL13583918 0.79 SLC7A5 (0.44) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL12091193 0.78 MMP1 (0.45) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL6892557 0.78 MMP1 (0.67) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL19846192 0.77 MMP1 (0.44) SLC1A2SLC1A1SLC1A3MMP1MMP2
SCHEMBL19846183 0.77 SLC1A3 (0.45) SLC1A2SLC1A1SLC1A3MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147113-A ADMINISTERING TO TREAT NERVOUS SYSTEM AND BRAIN DISORDERS; GLUTAMATE UPTAKE INHIBITORS SUNTORY LIMITED (JP) 2000-11-14 US disclosed